Click for best price
Antidepressants Drugs Market Size, Share 2022
Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.
This report contains market size and forecasts of Antidepressants Drugs in Global, including the following market information:
Global Antidepressants Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antidepressants Drugs market was valued at 14770 million in 2021 and is projected to reach US$ 18370 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tricyclic Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antidepressants Drugs include Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter and Janssen Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antidepressants Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidepressants Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antidepressants Drugs Market Segment Percentages, by Type, 2021 (%)
Tricyclic Antidepressants
Serotonin-norepinephrine Inhibitors
Atypical Antipsychotics
Selective Serotonin Reuptake Inhibitors
Benzodiazepines
Tetracyclic Antidepressants
Monoamine Oxidase Inhibitors
Others
Global Antidepressants Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antidepressants Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Antidepressants Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antidepressants Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidepressants Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antidepressants Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Eli Lilly and Company
Novartis
GlaxoSmithKline
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Antidepressants Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antidepressants Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antidepressants Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antidepressants Drugs Overall Market Size
2.1 Global Antidepressants Drugs Market Size: 2021 VS 2028
2.2 Global Antidepressants Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antidepressants Drugs Players in Global Market
3.2 Top Global Antidepressants Drugs Companies Ranked by Revenue
3.3 Global Antidepressants Drugs Revenue by Companies
3.4 Top 3 and Top 5 Antidepressants Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antidepressants Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antidepressants Drugs Players in Global Market
3.6.1 List of Global Tier 1 Antidepressants Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Antidepressants Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Antidepressants Drugs Market Size Markets, 2021 & 2028
4.1.2 Tricyclic Antidepressants
4.1.3 Serotonin-norepinephrine Inhibitors
4.1.4 Atypical Antipsychotics
4.1.5 Selective Serotonin Reuptake Inhibitors
4.1.6 Benzodiazepines
4.1.7 Tetracyclic Antidepressants
4.1.8 Monoamine Oxidase Inhibitors
4.1.9 Others
4.2 By Type - Global Antidepressants Drugs Revenue & Forecasts
4.2.1 By Type - Global Antidepressants Drugs Revenue, 2017-2022
4.2.2 By Type - Global Antidepressants Drugs Revenue, 2023-2028
4.2.3 By Type - Global Antidepressants Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antidepressants Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Antidepressants Drugs Revenue & Forecasts
5.2.1 By Application - Global Antidepressants Drugs Revenue, 2017-2022
5.2.2 By Application - Global Antidepressants Drugs Revenue, 2023-2028
5.2.3 By Application - Global Antidepressants Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Antidepressants Drugs Market Size, 2021 & 2028
6.2 By Region - Global Antidepressants Drugs Revenue & Forecasts
6.2.1 By Region - Global Antidepressants Drugs Revenue, 2017-2022
6.2.2 By Region - Global Antidepressants Drugs Revenue, 2023-2028
6.2.3 By Region - Global Antidepressants Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Antidepressants Drugs Revenue, 2017-2028
6.3.2 US Antidepressants Drugs Market Size, 2017-2028
6.3.3 Canada Antidepressants Drugs Market Size, 2017-2028
6.3.4 Mexico Antidepressants Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Antidepressants Drugs Revenue, 2017-2028
6.4.2 Germany Antidepressants Drugs Market Size, 2017-2028
6.4.3 France Antidepressants Drugs Market Size, 2017-2028
6.4.4 U.K. Antidepressants Drugs Market Size, 2017-2028
6.4.5 Italy Antidepressants Drugs Market Size, 2017-2028
6.4.6 Russia Antidepressants Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Antidepressants Drugs Market Size, 2017-2028
6.4.8 Benelux Antidepressants Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Antidepressants Drugs Revenue, 2017-2028
6.5.2 China Antidepressants Drugs Market Size, 2017-2028
6.5.3 Japan Antidepressants Drugs Market Size, 2017-2028
6.5.4 South Korea Antidepressants Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Antidepressants Drugs Market Size, 2017-2028
6.5.6 India Antidepressants Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Antidepressants Drugs Revenue, 2017-2028
6.6.2 Brazil Antidepressants Drugs Market Size, 2017-2028
6.6.3 Argentina Antidepressants Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antidepressants Drugs Revenue, 2017-2028
6.7.2 Turkey Antidepressants Drugs Market Size, 2017-2028
6.7.3 Israel Antidepressants Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Antidepressants Drugs Market Size, 2017-2028
6.7.5 UAE Antidepressants Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Antidepressants Drugs Major Product Offerings
7.1.4 Pfizer Antidepressants Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Antidepressants Drugs Major Product Offerings
7.2.4 AstraZeneca Antidepressants Drugs Revenue in Global Market (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Eli Lilly and Company
7.3.1 Eli Lilly and Company Corporate Summary
7.3.2 Eli Lilly and Company Business Overview
7.3.3 Eli Lilly and Company Antidepressants Drugs Major Product Offerings
7.3.4 Eli Lilly and Company Antidepressants Drugs Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly and Company Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Antidepressants Drugs Major Product Offerings
7.4.4 Novartis Antidepressants Drugs Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Antidepressants Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Antidepressants Drugs Revenue in Global Market (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Otsuka Pharmaceutical
7.6.1 Otsuka Pharmaceutical Corporate Summary
7.6.2 Otsuka Pharmaceutical Business Overview
7.6.3 Otsuka Pharmaceutical Antidepressants Drugs Major Product Offerings
7.6.4 Otsuka Pharmaceutical Antidepressants Drugs Revenue in Global Market (2017-2022)
7.6.5 Otsuka Pharmaceutical Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Antidepressants Drugs Major Product Offerings
7.7.4 Abbott Laboratories Antidepressants Drugs Revenue in Global Market (2017-2022)
7.7.5 Abbott Laboratories Key News
7.8 Gedeon Richter
7.8.1 Gedeon Richter Corporate Summary
7.8.2 Gedeon Richter Business Overview
7.8.3 Gedeon Richter Antidepressants Drugs Major Product Offerings
7.8.4 Gedeon Richter Antidepressants Drugs Revenue in Global Market (2017-2022)
7.8.5 Gedeon Richter Key News
7.9 Janssen Pharmaceuticals
7.9.1 Janssen Pharmaceuticals Corporate Summary
7.9.2 Janssen Pharmaceuticals Business Overview
7.9.3 Janssen Pharmaceuticals Antidepressants Drugs Major Product Offerings
7.9.4 Janssen Pharmaceuticals Antidepressants Drugs Revenue in Global Market (2017-2022)
7.9.5 Janssen Pharmaceuticals Key News
7.10 Lupin Pharmaceuticals
7.10.1 Lupin Pharmaceuticals Corporate Summary
7.10.2 Lupin Pharmaceuticals Business Overview
7.10.3 Lupin Pharmaceuticals Antidepressants Drugs Major Product Offerings
7.10.4 Lupin Pharmaceuticals Antidepressants Drugs Revenue in Global Market (2017-2022)
7.10.5 Lupin Pharmaceuticals Key News
7.11 Luye Pharma
7.11.1 Luye Pharma Corporate Summary
7.11.2 Luye Pharma Business Overview
7.11.3 Luye Pharma Antidepressants Drugs Major Product Offerings
7.11.4 Luye Pharma Antidepressants Drugs Revenue in Global Market (2017-2022)
7.11.5 Luye Pharma Key News
7.12 MSI Methylation Sciences
7.12.1 MSI Methylation Sciences Corporate Summary
7.12.2 MSI Methylation Sciences Business Overview
7.12.3 MSI Methylation Sciences Antidepressants Drugs Major Product Offerings
7.12.4 MSI Methylation Sciences Antidepressants Drugs Revenue in Global Market (2017-2022)
7.12.5 MSI Methylation Sciences Key News
7.13 Naurex
7.13.1 Naurex Corporate Summary
7.13.2 Naurex Business Overview
7.13.3 Naurex Antidepressants Drugs Major Product Offerings
7.13.4 Naurex Antidepressants Drugs Revenue in Global Market (2017-2022)
7.13.5 Naurex Key News
7.14 SK Biopharmaceuticals
7.14.1 SK Biopharmaceuticals Corporate Summary
7.14.2 SK Biopharmaceuticals Business Overview
7.14.3 SK Biopharmaceuticals Antidepressants Drugs Major Product Offerings
7.14.4 SK Biopharmaceuticals Antidepressants Drugs Revenue in Global Market (2017-2022)
7.14.5 SK Biopharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antidepressants Drugs Market Opportunities & Trends in Global Market
Table 2. Antidepressants Drugs Market Drivers in Global Market
Table 3. Antidepressants Drugs Market Restraints in Global Market
Table 4. Key Players of Antidepressants Drugs in Global Market
Table 5. Top Antidepressants Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antidepressants Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antidepressants Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antidepressants Drugs Product Type
Table 9. List of Global Tier 1 Antidepressants Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antidepressants Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Antidepressants Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antidepressants Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antidepressants Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Antidepressants Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antidepressants Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antidepressants Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Antidepressants Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antidepressants Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antidepressants Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antidepressants Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antidepressants Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antidepressants Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antidepressants Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antidepressants Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antidepressants Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antidepressants Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antidepressants Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antidepressants Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antidepressants Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Antidepressants Drugs Product Offerings
Table 32. Pfizer Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Antidepressants Drugs Product Offerings
Table 35. AstraZeneca Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly and Company Corporate Summary
Table 37. Eli Lilly and Company Antidepressants Drugs Product Offerings
Table 38. Eli Lilly and Company Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Antidepressants Drugs Product Offerings
Table 41. Novartis Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Antidepressants Drugs Product Offerings
Table 44. GlaxoSmithKline Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Otsuka Pharmaceutical Corporate Summary
Table 46. Otsuka Pharmaceutical Antidepressants Drugs Product Offerings
Table 47. Otsuka Pharmaceutical Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Laboratories Corporate Summary
Table 49. Abbott Laboratories Antidepressants Drugs Product Offerings
Table 50. Abbott Laboratories Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Gedeon Richter Corporate Summary
Table 52. Gedeon Richter Antidepressants Drugs Product Offerings
Table 53. Gedeon Richter Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Janssen Pharmaceuticals Corporate Summary
Table 55. Janssen Pharmaceuticals Antidepressants Drugs Product Offerings
Table 56. Janssen Pharmaceuticals Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Lupin Pharmaceuticals Corporate Summary
Table 58. Lupin Pharmaceuticals Antidepressants Drugs Product Offerings
Table 59. Lupin Pharmaceuticals Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Luye Pharma Corporate Summary
Table 61. Luye Pharma Antidepressants Drugs Product Offerings
Table 62. Luye Pharma Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 63. MSI Methylation Sciences Corporate Summary
Table 64. MSI Methylation Sciences Antidepressants Drugs Product Offerings
Table 65. MSI Methylation Sciences Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Naurex Corporate Summary
Table 67. Naurex Antidepressants Drugs Product Offerings
Table 68. Naurex Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
Table 69. SK Biopharmaceuticals Corporate Summary
Table 70. SK Biopharmaceuticals Antidepressants Drugs Product Offerings
Table 71. SK Biopharmaceuticals Antidepressants Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Antidepressants Drugs Segment by Type in 2021
Figure 2. Antidepressants Drugs Segment by Application in 2021
Figure 3. Global Antidepressants Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antidepressants Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antidepressants Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antidepressants Drugs Revenue in 2021
Figure 8. By Type - Global Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 12. US Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 24. China Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antidepressants Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antidepressants Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly and Company Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Otsuka Pharmaceutical Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Laboratories Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gedeon Richter Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Janssen Pharmaceuticals Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Lupin Pharmaceuticals Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Luye Pharma Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. MSI Methylation Sciences Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Naurex Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. SK Biopharmaceuticals Antidepressants Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
